No pronounced differences were observed in the glucose-lowering effect of IDeg [ area under the glucose infusion rate ( GIR ) curve 0-24h after a single dose ( AUCGIR,0-24h , SD ) and maximum GIR after a single dose ( GIRmax , SD ) ] when injected in the thigh , abdomen or deltoid ( AUCGIR,0-24h , SD 2,572 , 2,833 and 2,960 mg/kg , respectively ) .